25 June 2018
6.30pm–8.30pm on 26 June 2018
This event will explore questions raised by Big Data, the 100,000 Genomes Project and the new national NHS Genomic Medicine Service. The event is produced by Progress Educational Trust in partnership with Genomics England, as part of the Genomics Conversation.
The discussion will be chaired by TIMANDRA HARKNESS (author of the book Big Data: Does Size Matter?), with speakers including PROFESSOR ANN DALTON (Sheffield Children’s Hospital), PROFESSOR ANTHONY BROOKES (University of Leicester), PROFESSOR TIM HUBBARD (Genomics England) and DR NATALIE BANNER (Understanding Patient Data).
This event is taking place at University College London‘s Institute of Child Health. Email sstarr [at] progress.org.uk to book your FREE place(s).
22 November 2016
Progress Educational Trust public conference
Wednesday 7 December 2016, 9.30am–5pm
Speakers include PROFESSOR MAGDALENA ZERNICKA-GOETZ from the University of Cambridge (leader of recent research in which human embryos were cultured in vitro for 13 days, the longest time ever achieved), DR KATHY NIAKAN from the Francis Crick Institute (the first researcher licensed by the UK regulator to use genome editing in human embryo research), and LORD GEORGE CAREY from the House of Lords (former Archbishop of Canterbury).
There will also be Keynote Addresses by BARONESS MARY WARNOCK (who originally proposed the 14-day limit on human embryo research, and whose Warnock Report is arguably the world’s most influential analysis of the ethics of assisted reproduction and embryo research) and PROFESSOR SIR IAN WILMUT (creator of Dolly the sheep, the first mammal ever cloned from an adult cell).
Other confirmed speakers and chairs include:
• DR SIMON FISHEL (Founder and President of CARE Fertility, and one of the first researchers to demonstrate that embryos are capable of responding to their environment)
• PROFESSOR BRUCE WHITELAW (Deputy Director of the Roslin Institute, and pioneer in research involving transgenic and genome-edited animals)
• SALLY CHESHIRE (Chair of the Human Fertilisation and Embryology Authority)
• PROFESSOR ALISON MURDOCH (Former Director of the Newcastle Fertility Centre, and leader of the first research in which an early embryo was created from a human nuclear transfer procedure)
• PROFESSOR DAVID JONES (Director of the Anscombe Bioethics Centre)
• PROFESSOR SARAH FRANKLIN (Director of the University of Cambridge‘s Reproductive Sociology Research Group)
• PROFESSOR STEPHEN WILKINSON (bioethicist and author of the book Choosing Tomorrow’s Children: The Ethics Of Selective Reproduction)
• DR ROGER HIGHFIELD (Director of External Affairs at the Science Museum Group)
• FIONA FOX (Chair of the Progress Educational Trust and Chief Executive of the Science Media Centre)
• SARAH NORCROSS (Director of the Progress Educational Trust)
Conference sessions include:
• ‘THE WARNOCK REPORT AND THE 14 DAY RULE‘
• ‘THE 14 DAY RULE: CALLING TIME ON EMBRYO RESEARCH‘
• ‘GENOME EDITING: CRISPR AT THE CUTTING EDGE‘
• ‘WHAT’S SO SPECIAL ABOUT THE STATUS OF THE EMBRYO?‘
6 January 2015
Friday 30th January 2015, 09:30 – 16:30, Sheffield Law School
Sheffield Institute for Biotechnology Law and Ethics (SIBLE) and the Wellcome Trust are holding a symposium to consider the appropriate use of patient health and genetic data by commercial organisations.
The symposium will provide an opportunity to hear and discuss the approach to commercial access to data taken by some key national and international projects and resources. There is evidence that commercial access to data is relevant to public confidence in the safeguards and governance designed to protect health and genetic data. What controls on access currently exist? To what extent do these controls currently regulate access by commercial organisations?
This is an opportunity to share current practice and consider alternative views on commercial access to genetic and health data in the future. From a commercial perspective, what are potential uses of genetic and health data in practice? From a patient and public perspective, what approach toward regulating access to commercial organisations, or for commercial use, might best promote public trust and confidence?
The event is open to anyone interested in the issues and may be relevant to policy makers, those responsible for managing access to health and genetic resources, patients, and members of the public.
Programme and booking information here.
For enquiries relating to this event please contact the Research Support Team at the School of Law: email@example.com
7 November 2013
Policy Analyst (Biomedical Law and Regulation)
£35 – 40K per annum plus benefits
Full time or part time (min 28 hours p.w.)
The PHG Foundation is looking for a talented and enthusiastic professional with a legal background who is passionate about seeing biomedical research translated effectively into healthcare. Working as part of a multidisciplinary team, your role will be to provide sound legal and regulatory analysis for the Foundation’s health policy projects.
We are open-minded about background, but you must have a good first degree in law, social science, philosophy or similar subject; an excellent grasp of the legal, regulatory and ethical landscape around genomics and health; and first class analytical, drafting and communication skills. A postgraduate qualification in medical law, ethics or similar would be a distinct advantage but, most importantly, you must be able to transfer your academic grounding into actionable policy applications.
You will be an excellent networker and have the personal qualities to work creatively and effectively in a small team of highly-motivated colleagues who are committed to developing the PHG Foundation as an international health policy institute.
The Foundation is an equal opportunity employer.
The deadline for applications is 5pm, Thursday 14 November 2013. Interviews will be held in Cambridge on 25 November 2013.
9 February 2011
Duke Law School
Duke University’s Center for Public Genomics (CpG) is seeking a Fellow to work at Duke Law School for a one- or two-year term beginning in the summer or fall of 2011. The CpG was established in 2004 to understand the benefits and risks of intellectual property protections in genomics. The CpG is funded by the National Human Genome Research Institute and is a national Center of Excellence in Ethical, Legal, and Social Implications Research. Duke schools affiliated with the CpG include Duke Law School.
The Fellow will be responsible for a variety of tasks within the CpG that are centered at Duke Law School. His or her focus will be the “Genomics as Information” Project, which seeks to identify, analyze, and propose policy responses to ownership challenges raised as genomic research becomes increasingly based on pure information. The Fellow will conduct research as part of a team led by the Principal Investigator of the project, Professor Arti Rai. The team also includes professors at the Columbia School of Public Health, Harvard Medical School, and various research assistants.
Qualified candidates should hold an advanced degree in law (J.D.). Coursework or practice in the area of intellectual property required. A scientific or technical background is desirable, but not required. Familiarity with statistics and statistical programs (e.g. STATA) is desirable, but not required. Salary is approximately $45,000 to $50,000 annually, depending upon experience.
For additional details and application procedures, visit the Duke Center for Genome Ethics, Law & Policy website.